Blue Jet Healthcare Q2 FY27 Standalone Revenue at ₹3,757 Crore, Profit at ₹1,025 Crore
Blue Jet Healthcare's standalone Q2 FY27 revenue reached ₹3,757 crore, with a profit of ₹1,025 crore. For H1 FY27, revenue was ₹6,688 crore and profit was ₹1,807 crore. The company raised ₹8,000 crore via QIP by allotting 1.58 crore shares at ₹506 each.
The announcement includes strong financial performance and a substantial capital raise through QIP, which can significantly impact the company's financial structure, growth prospects, and market valuation.
The company reported strong financial results with increased revenue and profit for the quarter and half-year. The successful Qualified Institutional Placement (QIP) also indicates positive investor confidence and significant capital infusion.
Blue Jet Healthcare Limited announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company's Board of Directors approved these results in a meeting held on November 5, 2026.
For the quarter ended September 30, 2026, Blue Jet Healthcare reported total income of ₹4,019.52 crore, with revenue from operations at ₹3,757.44 crore. Total expenses were ₹2,645.58 crore, leading to a profit before tax of ₹1,373.94 crore. After accounting for tax expenses of ₹348.77 crore, the profit for the period stood at ₹1,025.17 crore. Earnings per share (EPS) for the quarter were ₹5.46 (basic and diluted).
For the half-year ended September 30, 2026, total income was ₹7,103.01 crore, and revenue from operations was ₹6,688.57 crore. Total expenses amounted to ₹4,669.61 crore, resulting in a profit before tax of ₹2,433.40 crore. The profit for the half-year, after tax expenses of ₹625.59 crore, was ₹1,807.81 crore. The EPS for the half-year was ₹10.00 (basic and diluted).
The company also reported a significant event during the quarter, wherein it allotted 1,58,10,276 equity shares of face value of ₹2 each at an issue price of ₹506 per equity share to eligible Qualified Institutional Buyers (QIBs). This Qualified Institutional Placement (QIP) aggregated to ₹8,000.00 crore (approximately $958 million), in accordance with SEBI ICDR Regulations. The company's total equity share capital increased to ₹378.55 crore and other equity to ₹22,607.38 crore as of September 30, 2026.
The board meeting commenced at 12:15 PM and concluded at 12:41 PM. The financial results were reviewed by the Audit Committee and the Statutory Auditor.
What to do with a filing like this
Blue Jet Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Blue Jet Healthcare Limited. Read the original for the full detail.